Friday, July 10, 2026

Drug profile · INN

ledipasvir acetonate/sofosbuvir

ledipasvir acetonate/sofosbuvir (HARVONI) is an FDA-listed pharmaceutical active ingredient.

PMDA: approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — ledipasvir acetonate/sofosbuvir
Class
Route
Patents
0
Programs
1
Data quality
0.78

Quick answer

ledipasvir acetonate/sofosbuvir (HARVONI) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN ledipasvir acetonate/sofosbuvir
Brand HARVONI

Approval history

Authority Status Date
PMDA approved

Pipeline programs

  1. Harvoni (Fixed dose combination ledipasvir/sofosbuvir) Approved · BRIGHT MINDS BIOSCIENCES · Hepatitis C

Frequently asked questions

What is ledipasvir acetonate/sofosbuvir?

ledipasvir acetonate/sofosbuvir (HARVONI) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for ledipasvir acetonate/sofosbuvir?

HARVONI is a marketed brand name for ledipasvir acetonate/sofosbuvir. Check FDA Drugs@FDA for the current US label holder and prescribing information.